{"transactions":[{"id":4619336,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-09-16T20:20:58.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":85000,"derivative":{"exercise_price":27.99,"expiration_date":"2036-09-13","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001823381-26-000014","document":"form4-09162026_080954.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000182338126000014/form4-09162026_080954.xml","form_type":"4"}},{"id":4619335,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-09-16T20:20:58.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":29000,"source":{"system":"sec-edgar","filing":"0001823381-26-000014","document":"form4-09162026_080954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000182338126000014/form4-09162026_080954.xml","form_type":"4"}},{"id":684462,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-18T22:51:48.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":2632,"price":4.39,"value":11554.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":87475,"source":{"system":"sec-edgar","filing":"0001484612-26-000048","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461226000048/edgardoc.xml","form_type":"4"}},{"id":724737,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-06-29T23:17:30.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":59830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on June 26, 2026. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on June 26, 2027, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on  February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":90107,"source":{"system":"sec-edgar","filing":"0001484612-26-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461226000045/edgardoc.xml","form_type":"4"}},{"id":773232,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-05-20T01:08:14.000Z","date":"2026-05-15","kind":"sale","planned":false,"acquired":false,"shares":2638,"price":3.7,"value":9760.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance reflects a correction to the number of shares of Common Stock sold by the reporting person to satisfy tax withholding obligations as previously reported on a Form 4 filed on February 19, 2026. Due to an administrative error, the prior Form 4 reported the sale of 2,842 shares instead of the correct number, 2,862 shares."}],"balance_after":30277,"source":{"system":"sec-edgar","filing":"0001484612-26-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461226000025/edgardoc.xml","form_type":"4"}},{"id":894486,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-02-20T01:57:47.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":2842,"price":3.35,"value":9520.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 5,032 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":32935,"source":{"system":"sec-edgar","filing":"0001823381-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000182338126000006/edgardoc.xml","form_type":"4"}},{"id":934643,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-01-22T00:05:50.000Z","date":"2026-01-21","kind":"sale","planned":false,"acquired":false,"shares":1180,"price":5.01,"value":5911.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 17,997 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":35777,"source":{"system":"sec-edgar","filing":"0001484612-26-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461226000017/edgardoc.xml","form_type":"4"}},{"id":934642,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-01-22T00:05:50.000Z","date":"2026-01-20","kind":"sale","planned":false,"acquired":false,"shares":9314,"price":5.12,"value":47687.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 17,997 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":36957,"source":{"system":"sec-edgar","filing":"0001484612-26-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461226000017/edgardoc.xml","form_type":"4"}},{"id":943612,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-01-08T22:09:01.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":224,"price":4.27,"value":956.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 447 shares of Common Stock underlying PSUs (i) which were, as previously reported, originally earned based on the achievement of applicable performance criteria as of December 31, 2024 or January 6, 2025, as applicable, as certified by the Compensation Committee of the Issuer's Board of Directors on January 17, 2025 and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":46271,"source":{"system":"sec-edgar","filing":"0001484612-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461226000005/edgardoc.xml","form_type":"4"}},{"id":996810,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-11-18T21:28:49.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":388,"price":4.6,"value":1784.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 748 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":46495,"source":{"system":"sec-edgar","filing":"0001484612-25-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000078/edgardoc.xml","form_type":"4"}},{"id":1064585,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-18T20:00:16.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":383,"price":12.88,"value":4933.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 748 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":46883,"source":{"system":"sec-edgar","filing":"0001484612-25-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000070/edgardoc.xml","form_type":"4"}},{"id":1115630,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-06-11T21:33:48.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":35993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on June 10, 2025. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 50% on January 17, 2026, and the remaining 50% shall vest in equal installments over the course of the following year on a quarterly basis on  February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":47266,"source":{"system":"sec-edgar","filing":"0001484612-25-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000061/edgardoc.xml","form_type":"4"}},{"id":1146218,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-05-16T21:21:39.000Z","date":"2025-05-15","kind":"sale","planned":false,"acquired":false,"shares":396,"price":17.82,"value":7056.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 748 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the \"Reverse Stock Split\")."}],"balance_after":11273,"source":{"system":"sec-edgar","filing":"0001484612-25-000046","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000046/edgardoc.xml","form_type":"4"}},{"id":1261854,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-02-19T21:26:21.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":6145,"price":0.9,"value":5530.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 11,934 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":175043,"source":{"system":"sec-edgar","filing":"0001484612-25-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000031/edgardoc.xml","form_type":"4"}},{"id":1298216,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-22T23:03:12.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":2679,"price":0.8,"value":2143.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 50% of the PSUs, described in footnote (1) above, on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":181188,"source":{"system":"sec-edgar","filing":"0001484612-25-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000023/edgardoc.xml","form_type":"4"}},{"id":1298215,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-22T23:03:12.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":29474,"price":0.8,"value":23579.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 50,000 shares of Common Stock underlying PRSUs which (i) represent 50% of the target shares underlying the original award (granted on January 12, 2024, as previously reported), which were earned based on performance as of December 31, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors, and (ii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":183867,"source":{"system":"sec-edgar","filing":"0001484612-25-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000023/edgardoc.xml","form_type":"4"}},{"id":1298214,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-22T23:03:12.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":777,"price":0.8,"value":621.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 1,318 shares of Common Stock underlying PSUs which (i) were, as previously reported, granted to the reporting person on January 26, 2022, (ii) were earned as of January 26, 2024 as certified by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (iii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":213341,"source":{"system":"sec-edgar","filing":"0001484612-25-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000023/edgardoc.xml","form_type":"4"}},{"id":1298213,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-22T23:03:12.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":9090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 6, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024.   The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria.   Each PSU represents a contingent right to receive a share of common stock.   These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period."}],"balance_after":214118,"source":{"system":"sec-edgar","filing":"0001484612-25-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000023/edgardoc.xml","form_type":"4"}},{"id":1304539,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-13T23:34:11.000Z","date":"2025-01-13","kind":"sale","planned":false,"acquired":false,"shares":20492,"price":0.81,"value":16598.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 31,996 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":205028,"source":{"system":"sec-edgar","filing":"0001484612-25-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000014/edgardoc.xml","form_type":"4"}},{"id":1308969,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-08T00:26:51.000Z","date":"2025-01-07","kind":"sale","planned":false,"acquired":false,"shares":1572,"price":1.29,"value":2027.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 2,530 shares of Common Stock underlying PSUs which (i) were, as previously reported, originally earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":225520,"source":{"system":"sec-edgar","filing":"0001484612-25-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000006/edgardoc.xml","form_type":"4"}},{"id":1362560,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-11-18T22:45:53.000Z","date":"2024-11-15","kind":"sale","planned":false,"acquired":false,"shares":3203,"price":0.8,"value":2562.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,888 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":227092,"source":{"system":"sec-edgar","filing":"0001484612-24-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461224000072/edgardoc.xml","form_type":"4"}},{"id":1432923,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-08-15T23:59:11.000Z","date":"2024-08-15","kind":"sale","planned":false,"acquired":false,"shares":3011,"price":0.84,"value":2529.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,887 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":230295,"source":{"system":"sec-edgar","filing":"0001484612-24-000064","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461224000064/edgardoc.xml","form_type":"4"}},{"id":1479763,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-06-14T20:17:26.000Z","date":"2024-06-12","kind":"sale","planned":false,"acquired":false,"shares":10569,"price":4.78,"value":50519.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $4.77 - $4.81. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":233306,"source":{"system":"sec-edgar","filing":"0001484612-24-000058","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461224000058/edgardoc.xml","form_type":"4"}},{"id":1512464,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-05-17T21:36:02.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":2972,"price":3.53,"value":10491.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,887 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c)."}],"balance_after":243875,"source":{"system":"sec-edgar","filing":"0001484612-24-000047","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461224000047/edgardoc.xml","form_type":"4"}},{"id":1639368,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-02-16T22:26:25.000Z","date":"2024-02-15","kind":"sale","planned":false,"acquired":false,"shares":3341,"price":3.57,"value":11927.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,891 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":245046,"source":{"system":"sec-edgar","filing":"0001484612-24-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461224000028/edgardoc.xml","form_type":"4"}},{"id":1678438,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-01-18T01:00:23.000Z","date":"2024-01-16","kind":"sale","planned":false,"acquired":false,"shares":1480,"price":4.29,"value":6349.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs on January 12, 2024 described in footnote (3) above. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":248387,"source":{"system":"sec-edgar","filing":"0001484612-24-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461224000015/edgardoc.xml","form_type":"4"}},{"id":1678437,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-01-18T01:00:23.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":5060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On January 26, 2022, the reporting person was granted performance-based restricted stock units (\"PSUs\") subject to the satisfaction of specified performance criteria as of December 31, 2023.  The reported amount represents the number of PSUs earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive one share of common stock. These PSUs vested 50% on January 12, 2024, and the remaining 50% shall vest on December 31, 2024, subject to the reporting person's continuous service through the vesting date."}],"balance_after":249867,"source":{"system":"sec-edgar","filing":"0001484612-24-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461224000015/edgardoc.xml","form_type":"4"}},{"id":1678436,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-01-18T01:00:23.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents performance-based restricted stock units (\"PSUs\") granted to the reporting person on January 12, 2024, that vest over a three year period based on the Issuer's common stock achieving specified prices per share, if not earlier vested upon satisfaction of specified performance criteria, subject to the reporting person's continuous service through the applicable vesting date. Each PSU represents a contingent right to receive one share of common stock."}],"balance_after":244807,"source":{"system":"sec-edgar","filing":"0001484612-24-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461224000015/edgardoc.xml","form_type":"4"}},{"id":1678435,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-01-18T01:00:23.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on January 12, 2024. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 12, 2025, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":144807,"source":{"system":"sec-edgar","filing":"0001484612-24-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461224000015/edgardoc.xml","form_type":"4"}},{"id":1684713,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-01-09T01:30:56.000Z","date":"2024-01-08","kind":"sale","planned":false,"acquired":false,"shares":7344,"price":5.49,"value":40318.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 12,944 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":48807,"source":{"system":"sec-edgar","filing":"0001484612-24-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461224000008/edgardoc.xml","form_type":"4"}},{"id":1737677,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-11-17T21:15:02.000Z","date":"2023-11-16","kind":"sale","planned":false,"acquired":false,"shares":1431,"price":4.76,"value":6811.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 2,651 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021 and January 26, 2022. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1 share of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\"), for the purchase period of March 1, 2023 to August 31, 2023. This transaction is exempt from Rule 16b-3(c)."}],"balance_after":56151,"source":{"system":"sec-edgar","filing":"0001484612-23-000086","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000086/edgardoc.xml","form_type":"4"}},{"id":1804507,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-08-17T20:28:13.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":1364,"price":15.1,"value":20596.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 2,652 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021 and January 26, 2022. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":57581,"source":{"system":"sec-edgar","filing":"0001484612-23-000068","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000068/edgardoc.xml","form_type":"4"}},{"id":1826126,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-07-20T20:01:26.000Z","date":"2023-07-19","kind":"exercise","planned":true,"acquired":false,"shares":1415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":15560,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":1415},"source":{"system":"sec-edgar","filing":"0001484612-23-000054","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000054/edgardoc.xml","form_type":"4"}},{"id":1826125,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-07-20T20:01:26.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":1415,"price":20,"value":28300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023."}],"balance_after":58945,"source":{"system":"sec-edgar","filing":"0001484612-23-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000054/edgardoc.xml","form_type":"4"}},{"id":1826124,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-07-20T20:01:26.000Z","date":"2023-07-19","kind":"exercise","planned":true,"acquired":true,"shares":1415,"price":9.48,"value":13414.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023."}],"balance_after":60360,"source":{"system":"sec-edgar","filing":"0001484612-23-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000054/edgardoc.xml","form_type":"4"}},{"id":1848217,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-21T20:01:38.000Z","date":"2023-06-20","kind":"exercise","planned":true,"acquired":false,"shares":1414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":16975,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":1414},"source":{"system":"sec-edgar","filing":"0001484612-23-000051","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000051/edgardoc.xml","form_type":"4"}},{"id":1848216,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-06-21T20:01:38.000Z","date":"2023-06-20","kind":"sale","planned":true,"acquired":false,"shares":1414,"price":21.97,"value":31065.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023."}],"balance_after":58945,"source":{"system":"sec-edgar","filing":"0001484612-23-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000051/edgardoc.xml","form_type":"4"}},{"id":1848215,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-06-21T20:01:38.000Z","date":"2023-06-20","kind":"exercise","planned":true,"acquired":true,"shares":1414,"price":9.48,"value":13404.72,"ownership":{"direct":true},"balance_after":60359,"source":{"system":"sec-edgar","filing":"0001484612-23-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000051/edgardoc.xml","form_type":"4"}},{"id":1890058,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-05-17T22:26:23.000Z","date":"2023-05-17","kind":"exercise","planned":true,"acquired":false,"shares":1415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":18389,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":1415},"source":{"system":"sec-edgar","filing":"0001484612-23-000041","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000041/edgardoc.xml","form_type":"4"}},{"id":1890057,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-05-17T22:26:23.000Z","date":"2023-05-17","kind":"sale","planned":true,"acquired":false,"shares":1317,"price":20.08,"value":26445.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023."}],"balance_after":58945,"source":{"system":"sec-edgar","filing":"0001484612-23-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000041/edgardoc.xml","form_type":"4"}},{"id":1890056,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-05-17T22:26:23.000Z","date":"2023-05-17","kind":"sale","planned":true,"acquired":false,"shares":1415,"price":20.08,"value":28413.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023."}],"balance_after":60262,"source":{"system":"sec-edgar","filing":"0001484612-23-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000041/edgardoc.xml","form_type":"4"}},{"id":1890055,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-05-17T22:26:23.000Z","date":"2023-05-17","kind":"exercise","planned":true,"acquired":true,"shares":1415,"price":9.48,"value":13414.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023."}],"balance_after":61677,"source":{"system":"sec-edgar","filing":"0001484612-23-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000041/edgardoc.xml","form_type":"4"}},{"id":1890054,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-05-17T22:26:23.000Z","date":"2023-05-16","kind":"sale","planned":true,"acquired":false,"shares":1335,"price":19.91,"value":26579.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":60262,"source":{"system":"sec-edgar","filing":"0001484612-23-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000041/edgardoc.xml","form_type":"4"}},{"id":1903345,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-05-05T22:13:53.000Z","date":"2023-05-03","kind":"exercise","planned":true,"acquired":false,"shares":1414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":19804,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":1414},"source":{"system":"sec-edgar","filing":"0001484612-23-000033","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000033/edgardoc.xml","form_type":"4"}},{"id":1903344,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-05-05T22:13:53.000Z","date":"2023-05-03","kind":"sale","planned":true,"acquired":false,"shares":1414,"price":20,"value":28280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023."}],"balance_after":61597,"source":{"system":"sec-edgar","filing":"0001484612-23-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000033/edgardoc.xml","form_type":"4"}},{"id":1903343,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-05-05T22:13:53.000Z","date":"2023-05-03","kind":"exercise","planned":true,"acquired":true,"shares":1414,"price":9.48,"value":13404.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023."}],"balance_after":63011,"source":{"system":"sec-edgar","filing":"0001484612-23-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000033/edgardoc.xml","form_type":"4"}},{"id":1943635,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-03-21T20:30:29.000Z","date":"2023-03-20","kind":"exercise","planned":false,"acquired":false,"shares":1415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":21218,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":1415},"source":{"system":"sec-edgar","filing":"0001140361-23-012810","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000114036123012810/form4.xml","form_type":"4"}},{"id":1943634,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-03-21T20:30:29.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":2715,"price":20.82,"value":56526.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 17, 2023."}],"balance_after":61597,"source":{"system":"sec-edgar","filing":"0001140361-23-012810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000114036123012810/form4.xml","form_type":"4"}},{"id":1943633,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-03-21T20:30:29.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":1415,"price":20.82,"value":29460.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 17, 2023."}],"balance_after":64312,"source":{"system":"sec-edgar","filing":"0001140361-23-012810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000114036123012810/form4.xml","form_type":"4"}},{"id":1943632,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-03-21T20:30:29.000Z","date":"2023-03-20","kind":"exercise","planned":false,"acquired":true,"shares":1415,"price":9.48,"value":13414.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c)."}],"balance_after":65727,"source":{"system":"sec-edgar","filing":"0001140361-23-012810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000114036123012810/form4.xml","form_type":"4"}},{"id":2009016,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Performance Options (right to buy)","published_at":"2023-02-17T21:15:39.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":2265},"source":{"system":"sec-edgar","filing":"0001484612-23-000025","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000025/edgardoc.xml","form_type":"4"}},{"id":2009015,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-02-17T21:15:39.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":2829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":22633,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":2829},"source":{"system":"sec-edgar","filing":"0001484612-23-000025","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000025/edgardoc.xml","form_type":"4"}},{"id":2009014,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-02-17T21:15:39.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":3532,"price":24.22,"value":85545.04,"ownership":{"direct":true},"balance_after":62890,"source":{"system":"sec-edgar","filing":"0001484612-23-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000025/edgardoc.xml","form_type":"4"}},{"id":2009013,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-02-17T21:15:39.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":2829,"price":23.9556,"value":67770.3924,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $23.00-$23.99 - 3,486 shares; $24.00-$24.99 - 1,608 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":66422,"source":{"system":"sec-edgar","filing":"0001484612-23-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000025/edgardoc.xml","form_type":"4"}},{"id":2009012,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-02-17T21:15:39.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":2829,"price":9.48,"value":26818.92,"ownership":{"direct":true},"balance_after":69251,"source":{"system":"sec-edgar","filing":"0001484612-23-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000025/edgardoc.xml","form_type":"4"}},{"id":2009011,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-02-17T21:15:39.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":2265,"price":23.9556,"value":54259.434,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $23.00-$23.99 - 3,486 shares; $24.00-$24.99 - 1,608 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":66422,"source":{"system":"sec-edgar","filing":"0001484612-23-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000025/edgardoc.xml","form_type":"4"}},{"id":2009010,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-02-17T21:15:39.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":2265,"price":9.48,"value":21472.2,"ownership":{"direct":true},"balance_after":68687,"source":{"system":"sec-edgar","filing":"0001484612-23-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000025/edgardoc.xml","form_type":"4"}},{"id":2012022,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-02-17T01:35:41.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":1000,"price":24.36,"value":24360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,953 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022.  This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":66422,"source":{"system":"sec-edgar","filing":"0001484612-23-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000018/edgardoc.xml","form_type":"4"}},{"id":2012021,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-02-17T01:35:41.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":358,"price":24.36,"value":8720.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 698 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021.  This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":67422,"source":{"system":"sec-edgar","filing":"0001484612-23-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000018/edgardoc.xml","form_type":"4"}},{"id":2042710,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-01-30T21:42:21.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":4282,"price":27.92,"value":119553.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 7,814 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":67780,"source":{"system":"sec-edgar","filing":"0001484612-23-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000011/edgardoc.xml","form_type":"4"}},{"id":2059334,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-01-09T21:55:04.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":2184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date.  Each stock unit represents a contingent right to receive one share of common stock."}],"balance_after":72062,"source":{"system":"sec-edgar","filing":"0001484612-23-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000007/edgardoc.xml","form_type":"4"}},{"id":2059333,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-01-09T21:55:04.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":38834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":69878,"source":{"system":"sec-edgar","filing":"0001484612-23-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461223000007/edgardoc.xml","form_type":"4"}},{"id":2100465,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-12-02T01:00:45.000Z","date":"2022-11-30","kind":"exercise","acquired":false,"shares":12761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":25462,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":12761},"source":{"system":"sec-edgar","filing":"0001484612-22-000081","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000081/edgardoc.xml","form_type":"4"}},{"id":2100464,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-12-02T01:00:45.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":12761,"price":20.3352,"value":259497.4872,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $20.29 to $20.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote."}],"balance_after":31044,"source":{"system":"sec-edgar","filing":"0001484612-22-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000081/edgardoc.xml","form_type":"4"}},{"id":2100463,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-12-02T01:00:45.000Z","date":"2022-11-30","kind":"exercise","acquired":true,"shares":12761,"price":9.48,"value":120974.28,"ownership":{"direct":true},"balance_after":43805,"source":{"system":"sec-edgar","filing":"0001484612-22-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000081/edgardoc.xml","form_type":"4"}},{"id":2109230,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-11-22T01:30:44.000Z","date":"2022-11-18","kind":"sale","acquired":false,"shares":1918,"price":19,"value":36442.0,"ownership":{"direct":true},"balance_after":31044,"source":{"system":"sec-edgar","filing":"0001484612-22-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000079/edgardoc.xml","form_type":"4"}},{"id":2113086,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-11-17T21:29:48.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":352,"price":19.28,"value":6786.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 698 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":32962,"source":{"system":"sec-edgar","filing":"0001484612-22-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000078/edgardoc.xml","form_type":"4"}},{"id":2184808,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-08-16T22:14:37.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":351,"price":21.48,"value":7539.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 698 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":33314,"source":{"system":"sec-edgar","filing":"0001484612-22-000063","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000063/edgardoc.xml","form_type":"4"}},{"id":2268988,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-05-17T22:59:49.000Z","date":"2022-05-17","kind":"sale","acquired":false,"shares":349,"price":26.36,"value":9199.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 699 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":33665,"source":{"system":"sec-edgar","filing":"0001484612-22-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000038/edgardoc.xml","form_type":"4"}},{"id":2295947,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Performance Options (right to buy)","published_at":"2022-04-18T23:34:16.000Z","date":"2022-04-18","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested."}],"balance_after":2265,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001484612-22-000034","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000034/edgardoc.xml","form_type":"4"}},{"id":2295946,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-18T23:34:16.000Z","date":"2022-04-18","kind":"exercise","acquired":false,"shares":1415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":38223,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":1415},"source":{"system":"sec-edgar","filing":"0001484612-22-000034","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000034/edgardoc.xml","form_type":"4"}},{"id":2295945,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-04-18T23:34:16.000Z","date":"2022-04-18","kind":"sale","acquired":false,"shares":1415,"price":43.249,"value":61197.335,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $42.00-$42.99 - 672 shares; $43.00-$43.99 - 1,743 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":34014,"source":{"system":"sec-edgar","filing":"0001484612-22-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000034/edgardoc.xml","form_type":"4"}},{"id":2295944,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-04-18T23:34:16.000Z","date":"2022-04-18","kind":"exercise","acquired":true,"shares":1415,"price":9.48,"value":13414.2,"ownership":{"direct":true},"balance_after":35429,"source":{"system":"sec-edgar","filing":"0001484612-22-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000034/edgardoc.xml","form_type":"4"}},{"id":2295943,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-04-18T23:34:16.000Z","date":"2022-04-18","kind":"sale","acquired":false,"shares":1000,"price":43.249,"value":43249.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $42.00-$42.99 - 672 shares; $43.00-$43.99 - 1,743 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":34014,"source":{"system":"sec-edgar","filing":"0001484612-22-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000034/edgardoc.xml","form_type":"4"}},{"id":2295942,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-04-18T23:34:16.000Z","date":"2022-04-18","kind":"exercise","acquired":true,"shares":1000,"price":9.48,"value":9480.0,"ownership":{"direct":true},"balance_after":35014,"source":{"system":"sec-edgar","filing":"0001484612-22-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000034/edgardoc.xml","form_type":"4"}},{"id":2328961,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-03-17T22:53:28.000Z","date":"2022-03-17","kind":"sale","acquired":false,"shares":1400,"price":40.46,"value":56644.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021."}],"balance_after":34014,"source":{"system":"sec-edgar","filing":"0001484612-22-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000027/edgardoc.xml","form_type":"4"}},{"id":2328960,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-03-17T22:53:28.000Z","date":"2022-03-16","kind":"sale","acquired":false,"shares":1392,"price":39.77,"value":55359.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 2,792 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":35414,"source":{"system":"sec-edgar","filing":"0001484612-22-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000027/edgardoc.xml","form_type":"4"}},{"id":2334127,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Performance Options (right to buy)","published_at":"2022-03-15T23:56:27.000Z","date":"2022-03-15","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer (\"Share\") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event."}],"balance_after":3265,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001484612-22-000024","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000024/edgardoc.xml","form_type":"4"}},{"id":2334126,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-15T23:56:27.000Z","date":"2022-03-15","kind":"exercise","acquired":false,"shares":5586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":39638,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":5586},"source":{"system":"sec-edgar","filing":"0001484612-22-000024","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000024/edgardoc.xml","form_type":"4"}},{"id":2334125,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-03-15T23:56:27.000Z","date":"2022-03-15","kind":"sale","acquired":false,"shares":5586,"price":38.5886,"value":215555.9196,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $37.00-$37.99 - 1,200 shares; $38.00-$38.99 -  3,508 shares; $39.00-$39.99 - 1,878 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":36806,"source":{"system":"sec-edgar","filing":"0001484612-22-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000024/edgardoc.xml","form_type":"4"}},{"id":2334124,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-03-15T23:56:27.000Z","date":"2022-03-15","kind":"exercise","acquired":true,"shares":5586,"price":9.48,"value":52955.28,"ownership":{"direct":true},"balance_after":42392,"source":{"system":"sec-edgar","filing":"0001484612-22-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000024/edgardoc.xml","form_type":"4"}},{"id":2334123,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-03-15T23:56:27.000Z","date":"2022-03-15","kind":"sale","acquired":false,"shares":1000,"price":38.5886,"value":38588.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $37.00-$37.99 - 1,200 shares; $38.00-$38.99 -  3,508 shares; $39.00-$39.99 - 1,878 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":36806,"source":{"system":"sec-edgar","filing":"0001484612-22-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000024/edgardoc.xml","form_type":"4"}},{"id":2334122,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-03-15T23:56:27.000Z","date":"2022-03-15","kind":"exercise","acquired":true,"shares":1000,"price":9.48,"value":9480.0,"ownership":{"direct":true},"balance_after":37806,"source":{"system":"sec-edgar","filing":"0001484612-22-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000024/edgardoc.xml","form_type":"4"}},{"id":2362478,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-03-02T21:51:59.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":1003,"price":43.73,"value":43861.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 500 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\"), for the purchase period of September 1, 2021 to February 28, 2022. This transaction is exempt from Rule 16b-3(c)."}],"balance_after":36806,"source":{"system":"sec-edgar","filing":"0001484612-22-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000020/edgardoc.xml","form_type":"4"}},{"id":2389668,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Performance Options (right to buy)","published_at":"2022-02-17T22:58:43.000Z","date":"2022-02-15","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer (\"Share\") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event."}],"balance_after":4265,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001484612-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000018/edgardoc.xml","form_type":"4"}},{"id":2389667,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-02-17T22:58:43.000Z","date":"2022-02-15","kind":"exercise","acquired":false,"shares":7002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":45224,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":7002},"source":{"system":"sec-edgar","filing":"0001484612-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000018/edgardoc.xml","form_type":"4"}},{"id":2389666,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-02-17T22:58:43.000Z","date":"2022-02-15","kind":"sale","acquired":false,"shares":7002,"price":35.917,"value":251490.834,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 7,257 shares; $46.00-$46.99 - 2,745 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":37309,"source":{"system":"sec-edgar","filing":"0001484612-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000018/edgardoc.xml","form_type":"4"}},{"id":2389665,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-02-17T22:58:43.000Z","date":"2022-02-15","kind":"exercise","acquired":true,"shares":7002,"price":9.48,"value":66378.96,"ownership":{"direct":true},"balance_after":44311,"source":{"system":"sec-edgar","filing":"0001484612-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000018/edgardoc.xml","form_type":"4"}},{"id":2389664,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-02-17T22:58:43.000Z","date":"2022-02-15","kind":"sale","acquired":false,"shares":3000,"price":35.917,"value":107751.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 7,257 shares; $46.00-$46.99 - 2,745 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":37309,"source":{"system":"sec-edgar","filing":"0001484612-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000018/edgardoc.xml","form_type":"4"}},{"id":2389663,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-02-17T22:58:43.000Z","date":"2022-02-15","kind":"exercise","acquired":true,"shares":3000,"price":9.48,"value":28440.0,"ownership":{"direct":true},"balance_after":40309,"source":{"system":"sec-edgar","filing":"0001484612-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000018/edgardoc.xml","form_type":"4"}},{"id":2423117,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-01-28T21:46:31.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":1319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents portion of stock units granted to the reporting person on January 26, 2022 that will vest on December 31, 2024, subject only to the reporting person's continuous service through the vesting date.  Each stock unit represents a contingent right to receive one share of common stock."}],"balance_after":37309,"source":{"system":"sec-edgar","filing":"0001484612-22-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000010/edgardoc.xml","form_type":"4"}},{"id":2423116,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-01-28T21:46:31.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":23443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on January 26, 2022. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 26, 2023, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":35990,"source":{"system":"sec-edgar","filing":"0001484612-22-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000010/edgardoc.xml","form_type":"4"}},{"id":2432913,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Performance Options (right to buy)","published_at":"2022-01-20T01:52:00.000Z","date":"2022-01-18","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer (\"Share\") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event."}],"balance_after":7265,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001484612-22-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000007/edgardoc.xml","form_type":"4"}},{"id":2432912,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-01-20T01:52:00.000Z","date":"2022-01-18","kind":"exercise","acquired":false,"shares":7002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":52226,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":7002},"source":{"system":"sec-edgar","filing":"0001484612-22-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000007/edgardoc.xml","form_type":"4"}},{"id":2432911,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-01-20T01:52:00.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":7002,"price":35.6053,"value":249308.3106,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $34.00-$34.99 - 536 shares; $35.00-$35.99 - 5,814 shares; $36.00-$36.99 - 3,652 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12547,"source":{"system":"sec-edgar","filing":"0001484612-22-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000007/edgardoc.xml","form_type":"4"}},{"id":2432910,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-01-20T01:52:00.000Z","date":"2022-01-18","kind":"exercise","acquired":true,"shares":7002,"price":9.48,"value":66378.96,"ownership":{"direct":true},"balance_after":19549,"source":{"system":"sec-edgar","filing":"0001484612-22-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000007/edgardoc.xml","form_type":"4"}},{"id":2432909,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-01-20T01:52:00.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":3000,"price":35.6053,"value":106815.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $34.00-$34.99 - 536 shares; $35.00-$35.99 - 5,814 shares; $36.00-$36.99 - 3,652 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12547,"source":{"system":"sec-edgar","filing":"0001484612-22-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000007/edgardoc.xml","form_type":"4"}},{"id":2432908,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-01-20T01:52:00.000Z","date":"2022-01-18","kind":"exercise","acquired":true,"shares":3000,"price":9.48,"value":28440.0,"ownership":{"direct":true},"balance_after":15547,"source":{"system":"sec-edgar","filing":"0001484612-22-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000007/edgardoc.xml","form_type":"4"}},{"id":2451484,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-01-04T21:27:29.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":2500,"price":47.05,"value":117625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 250 shares; $46.00-$46.99 - 331 shares; $47.00-$47.99 - 1,819 shares; $48.00 - $48.99 - 100 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12547,"source":{"system":"sec-edgar","filing":"0001484612-22-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461222000002/edgardoc.xml","form_type":"4"}},{"id":2489587,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Performance Options (right to buy)","published_at":"2021-12-02T21:42:31.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer (\"Share\") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event."}],"balance_after":10265,"derivative":{"exercise_price":9.48,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001484612-21-000089","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461221000089/edgardoc.xml","form_type":"4"}}],"next_cursor":"2021-12-02T21:42:31.000000Z,2489587"}